BIOHM FX

Serial Number 88569895
Registration 6521359
700

Registration Progress

Application Filed
Aug 7, 2019
Under Examination
Mar 17, 2020
Approved for Publication
Jan 21, 2020
Published for Opposition
Jan 21, 2020
Registered
Oct 12, 2021

Basic Information

Serial Number
88569895
Registration Number
6521359
Filing Date
August 7, 2019
Registration Date
October 12, 2021
Published for Opposition
January 21, 2020
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 12, 2021
Registration
Registered
Classes
005

Rights Holder

BIOHM HEALTH INC.

99
Address
425 LITERARY ROAD
SUITE 100
CLEVELAND, OH 44113

Ownership History

PathoBiome LLC

Original Applicant
16
Cleveland, OH

BIOHM HEALTH LLC

New Owner Before Publication #1
16
CLEVELAND, OH

BIOHM HEALTH LLC

Owner at Publication
16
CLEVELAND, OH

BIOHM HEALTH LLC

Original Registrant
16
CLEVELAND, OH

BIOHM HEALTH INC.

New Owner After Registration #1
99
CLEVELAND, OH

Legal Representation

Attorney
Brian E. Turung
USPTO Deadlines 4 active 4 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUB Feb 20, 2020 1964 days overdue Medium Until Mar 20, 2020
ITU SOU
Notice of Allowance Mailed - SOU Required
NOAM Sep 17, 2020 1754 days overdue High Until Mar 17, 2021
OFFICE ACTION
Non-Final Action E-Mailed
GNRT Jun 30, 2021 1468 days overdue Critical Until Sep 30, 2021
OFFICE ACTION
Non-Final Action Mailed
CNRT Jun 30, 2021 1468 days overdue Critical Until Sep 30, 2021

Application History

38 events
Date Code Type Description
Feb 15, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 12, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Sep 9, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 8, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 1, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 1, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 1, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 31, 2021 CNRT W SU - NON-FINAL ACTION - WRITTEN
Mar 31, 2021 GNRT O NON-FINAL ACTION E-MAILED
Mar 31, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 30, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 30, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Mar 11, 2021 EISU I TEAS STATEMENT OF USE RECEIVED
Mar 11, 2021 IUAF S USE AMENDMENT FILED
Oct 5, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 5, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 5, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 5, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 5, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 18, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 16, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 16, 2020 EXT1 S SOU EXTENSION 1 FILED
Sep 16, 2020 EX1G S SOU EXTENSION 1 GRANTED
Mar 17, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 21, 2020 PUBO A PUBLISHED FOR OPPOSITION
Jan 21, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 1, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 16, 2019 ALIE A ASSIGNED TO LIE
Dec 12, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 3, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 3, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 3, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 27, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 6, 2019 DOCK D ASSIGNED TO EXAMINER
Nov 6, 2019 CNRT R NON-FINAL ACTION WRITTEN
Nov 6, 2019 GNRT F NON-FINAL ACTION E-MAILED
Nov 6, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 23, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Detailed Classifications

Class 005
Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; dietary supplements for medical use, and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; beverages containing probiotic compositions for use as a nutritional supplement; food supplements containing probiotic compositions; human food supplements products containing probiotic compositions, namely, probiotic supplements; animal food products containing probiotic compositions, namely, probiotic animal feed; dietary supplement drink mixes, namely, probiotic compositions in the form of mixes to added to beverages; dietary supplements in the nature of probiotic compositions for mixing with cereal
First Use Anywhere: Mar 9, 2021
First Use in Commerce: Mar 9, 2021

Classification

International Classes
005